ALS Patients Given NurOwn Calling for FDA Meeting to Discuss Refusal
People who took part in clinical testing of NurOwn, a cell therapy for amyotrophic lateral sclerosis (ALS), and family members…
Articles by Marisa Wexler, MS
Study Reveals How Growing Motor Neurons Guide Blood Vessel Growth
An international team of researchers discovered how, during development, motor neurons — the nerve cells controlling movement whose death causes…
PARADIGM Trial for PrimeC Set to Enroll Soon in US, Italy
NeuroSense Therapeutics has received the go-ahead to begin enrolling patients in the U.S. and Italy for a Phase 2b…
FDA Declines to Consider Approving NurOwn to Treat ALS
The U.S. Food and Drug Administration (FDA) notified Brainstorm Cell Therapeutics that it will not accept for review a company…
Verge Starts First-in-human Trial of Its Novel PIKfyve Inhibitor for ALS
Four years after its discovery via an artificial intelligence (AI) platform, Verge Genomics will test its amyotrophic lateral…
New Study Uncovers Mechanism of CuATSM, ALS Therapy Now in Trials
CuATSM, a potential amyotrophic lateral sclerosis (ALS) therapy that’s now in clinical trials, may work by altering how certain…
Air Pollution Exposure Tied to Greater ALS Risk in Women in Study
Higher long-term exposure to certain forms of air pollution — specifically coarse particulate matter, such as that from traffic pollutants…
Machine Learning May Help Predict ALS Progression
Deep machine-learning models using neural networks — computer algorithms inspired in the biological networks of the human brain —may help…
Earlier Start With Riluzole Could Help to Prolong Survival With ALS
Starting treatment with riluzole earlier in the disease course could prolong overall survival for people with amyotrophic lateral sclerosis…
Via Orphan Drug Grant Program, FDA Funds New ALS Research
The U.S. Food and Drug Administration (FDA) is funding several novel research projects related to amyotrophic lateral sclerosis (ALS)…